⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 2, 2024Open Access

Supplementary Figure 1 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy

Dong‐In Koh Minki Lee Yoon Sun Park Jae-Sik Shin Joseph Kim Yea Seong Ryu Jun Hyung Lee Seunggeon Bae Mi So Lee Jun Ki Hong Hong-Rae Jeong Mingee Choi Seung-Woo Hong Dong Kwan Kim Hyun-Kyung Lee Bomi Kim Yoo Sang Yoon Dong‐Hoon Jin

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

IGSF1 targeting antibody is developed and characterized by various methods

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Koh et al. (2024) studied this question.

synapsesocial.com/papers/68e70c4bb6db643587685eb5 https://doi.org/10.1158/2326-6066.25523117

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 1 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy2024
2Supplementary Figure 6 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy2024
3Supplementary Figure 6 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy2024
4Supplementary Figure 2 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy2024
5Supplementary Figure 2 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy2024

More related papers

Supplementary Figure 5 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy2024
Supplementary Figure 5 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy2024
Supplementary Figure 4 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy2024